CPA
Cowen Prime Advisors’s Nephros NEPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-42,500
| Closed | -$65K | – | 175 |
|
|
2022
Q2 | $65K | Sell |
42,500
-37,900
| -47% | -$58K | 0.04% | 107 |
|
|
2022
Q1 | $354K | Sell |
80,400
-552,650
| -87% | -$2.43M | 0.15% | 68 |
|
|
2021
Q4 | $3.74M | Sell |
633,050
-27,100
| -4% | -$160K | 1.27% | 18 |
|
|
2021
Q3 | $5.79M | Buy |
660,150
+33,700
| +5% | +$296K | 2.15% | 11 |
|
|
2021
Q2 | $6.36M | Buy |
626,450
+3,700
| +0.6% | +$37.6K | 2.31% | 12 |
|
|
2021
Q1 | $4.14M | Buy |
622,750
+47,673
| +8% | +$317K | 1.57% | 14 |
|
|
2020
Q4 | $4.93M | Buy |
575,077
+266,068
| +86% | +$2.28M | 2.19% | 11 |
|
|
2020
Q3 | $2.23M | Buy |
309,009
+266,509
| +627% | +$1.93M | 1.09% | 22 |
|
|
2020
Q2 | $65K | Sell |
42,500
-112,300
| -73% | -$172K | 0.04% | 107 |
|
|
2020
Q1 | $975K | Buy |
+154,800
| New | +$975K | 0.6% | 37 |
|